Potential Novartis blockbuster misses the mark in new study

Novartis ’ Entresto already has the potential to hit $3 billion in sales for its current heart failure indication, and with another indication in mind, the company hoped sales could hit $5 billion.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news